The Role of Euro SCORE and STS Prediction Systems in Prognosis of Candidates for Surgical Pulmonary Embolectomy at a Referral Hospital
Archives of Critical Care Medicine,
Vol. 3 No. 1 (2017),
31 October 2023
Abstract
Background: Pulmonary embolism (PE) is the only preventable cause of death in hospitalized patients with 15% mortality rate, which is increased to 25% among hemodynamically instable cases. The current study, regarding new concepts and techniques of risk assessment in pulmonary embolism, aimed at evaluating the role of STS score and EuroSCORE in prognosis forecast among cases of surgical embolectomy in patients with pulmonary embolism in order to suggest an acceptable way to reduce mortality rate in addition to optimum case selection for embolectomy.
Methods: Through a prospective cross-sectional study, 50 patients were recruited out of the total candidates for embolectomy at Massih Daneshvari hospital, during years 2016 and 2017. The participants were followed up for complications, morbidities, hospital stay, intensive care unit (ICU) admission and also mortality. Two scoring systems, as named before, were used and the results were compared considering the consequences of surgical embolectomy, such as hospital stay, morbidity and mortality, to finally suggest an association between the scores in each system and the outcomes.
Results: Fifty patients with pulmonary embolism, who were candidates for surgical embolectomy, entered the study. The mean age ± SD was 65.8 ± 14.1 and males made up 54.2% of the participants. The mean scores were significantly higher in patients, who died, compared with alive participants. The mean STS score was doubled in people who died while the EuroSCORE showed almost three-folded values in that group compared to survived individuals (P value < 0.001 and 0.003, respectively). The APACHE II score was significantly higher in dead participants (P value = 0.04) and they spent most of their hospitalization time at the ICU (78.2% versus 15.6% of the survived group) (P value = 0.01). The survived participants had lower rate of kidney injury as well (17% versus 29%; P value = 0.009), while the overall rate of the problem was 24% in 50 participants. There was a reverse correlation between STS and EuroSCORE obtained score and the length of stay that is not too far from the fact that individuals with worse conditions usually obtain higher scores and die faster than others.
Conclusions: To sum up, with a global acceptance in addition to ease of utilization, euroSCORE is approved by the clinicians disre[1]garding the overall controversy between the two predicting systems that were studied in terms of calibration and discrimination.
- EuroSCORE
- STS Prediction
- Pulmonary Embolectomy
How to Cite
References
Kiris T, Yazici S, Durmus G, Canga Y, Karaca M, Nazli C, et al. The relation between international normalized ratio and mortality in acute
pulmonary embolism: A retrospective study. J Clin Lab Anal. 2018;32(1).
doi: 10.1002/jcla.22164. [PubMed: 28213956].
Dudzinski DM, Giri J, Rosenfield K. Interventional Treatment
of Pulmonary Embolism. Circ Cardiovasc Interv. 2017;10(2). doi:
1161/CIRCINTERVENTIONS.116.004345. [PubMed: 28213377].
Dahhan T, Alenezi F, Samad Z, Rajagopal S. Echocardiography in
the Risk Assessment of Acute Pulmonary Embolism. Semin Respir
Crit Care Med. 2017;38(1):18–28. doi: 10.1055/s-0036-1597563. [PubMed:
.
Weinberg A, Tapson VF, Ramzy D. Massive Pulmonary Embolism: Extracorporeal Membrane Oxygenation and Surgical Pulmonary Embolectomy. Semin Respir Crit Care Med. 2017;38(1):66–72. doi: 10.1055/s0036-1597559. [PubMed: 28208200].
Ancion A, Melissopoulou M, Lancellotti P. [Diagnosis of acute pulmonary embolism. European guidelines]. Rev Med Liege. 2015;70(1):17–
[PubMed: 25902601].
Nemec P, Uchytil B, Cerny J, Ondrasek J, Pol J, Pokorny P. [Surgical treatment of pulmonary embolism]. Vnitr Lek. 2009;55(9):779–82.
[PubMed: 19785375].
Liang NL, Avgerinos ED, Singh MJ, Makaroun MS, Chaer RA. Systemic thrombolysis increases hemorrhagic stroke risk without survival benefit compared with catheter-directed intervention for the
treatment of acute pulmonary embolism. J Vasc Surg Venous Lymphat
Disord. 2017;5(2):171–176 e1. doi: 10.1016/j.jvsv.2016.11.005. [PubMed:
. [PubMed Central: PMC5324829].
Lehnert P, Moller CH, Mortensen J, Kjaergaard J, Olsen PS, Carlsen
J. Surgical embolectomy compared to thrombolysis in acute pulmonary embolism: morbidity and mortality. Eur J Cardiothorac Surg.
;51(2):354–61. doi: 10.1093/ejcts/ezw297. [PubMed: 28186234].
Kuwaki K, Inaba H, Yamamoto T, Dohi S, Matsumura T, Morita T, et
al. Performance of the EuroSCORE II and the Society of Thoracic Surgeons Score in patients undergoing aortic valve replacement for aortic stenosis. J Cardiovasc Surg (Torino). 2015;56(3):455–62. [PubMed:
.
Prins C, de Villiers Jonker I, Botes L, Smit FE. Cardiac surgery
risk-stratification models. Cardiovasc J Afr. 2012;23(3):160–4. doi:
5830/CVJA-2011-047. [PubMed: 22555640]. [PubMed Central:
PMC3721858].
Ad N, Barnett SD, Speir AM. The performance of the EuroSCORE
and the Society of Thoracic Surgeons mortality risk score: the
gender factor. Interact Cardiovasc Thorac Surg. 2007;6(2):192–5. doi:
1510/icvts.2006.138313. [PubMed: 17669807].
Rosa VE, Lopes AS, Accorsi TA, Fernandes JR, Spina GS, Sampaio RO, et
al. EuroSCORE II and STS as mortality predictors in patients undergoing TAVI. Rev Assoc Med Bras (1992). 2016;62(1):32–7. doi: 10.1590/1806-
62.01.32. [PubMed: 27008490].
Jamaati H, Najafi A, Kahe F, Karimi Z, Ahmadi Z, Bolursaz M, et al.
Assessment of the EuroSCORE risk scoring system for patients undergoing coronary artery bypass graft surgery in a group of Iranian
patients. Indian J Crit Care Med. 2015;19(10):576–9. doi: 10.4103/0972-
167033. [PubMed: 26628821]. [PubMed Central: PMC4637956].
Alizadeh K, Tabari M, Shirinzadeh Feizabadi A, Izanloo A. A report on
emergent pulmonary embolectomy. Cardiothorac Med. 2016;4(1):411–
Bach AG, Taute BM, Baasai N, Wienke A, Meyer HJ, Schramm D, et al.
-Day Mortality in Acute Pulmonary Embolism: Prognostic Value
of Clinical Scores and Anamnestic Features. PLoS One. 2016;11(2).
e0148728. doi: 10.1371/journal.pone.0148728. [PubMed: 26866472].
[PubMed Central: PMC4750907].
Vohra HA, Whistance RN, Mattam K, Kaarne M, Haw MP, Barlow
CW, et al. Early and late clinical outcomes of pulmonary embolectomy for acute massive pulmonary embolism. Ann Thorac Surg.
;90(6):1747–52. doi: 10.1016/j.athoracsur.2010.08.002. [PubMed:
.
Stahli BE, Tasnady H, Luscher TF, Gebhard C, Mikulicic F, Erhart L, et al.
Early and late mortality in patients undergoing transcatheter aortic
valve implantation: comparison of the novel EuroScore II with established risk scores. Cardiology. 2013;126(1):15–23. doi: 10.1159/000351438.
[PubMed: 23912448].
Rabbani MS, Qadir I, Ahmed Y, Gul M, Sharif H. Heart valve surgery:
EuroSCORE vs. EuroSCORE II vs. Society of Thoracic Surgeons score.
Heart Int. 2014;9(2):53–8. doi: 10.5301/heartint.5000214. [PubMed:
. [PubMed Central: PMC4774933].
Janikowski K, Morawiec R, Jegier B, Jaszewski R, Lelonek M. EuroSCORE II does not show better accuracy nor predictive power in
comparison to original EuroSCORE: a single-centre study. Kardiol Pol.
;74(5):469–75. doi: 10.5603/KP.a2015.0215. [PubMed: 26575309].
Iung B, Vahanian A. Towards improved risk scores: the quest for
the grail continues. Eur Heart J. 2013;34(1):10–2. doi: 10.1093/eurheartj/ehs343. [PubMed: 23028170].
Barili F, Pacini D, Capo A, Rasovic O, Grossi C, Alamanni F, et al. Does
EuroSCORE II perform better than its original versions? A multicentre validation study. Eur Heart J. 2013;34(1):22–9. doi: 10.1093/eurheartj/ehs342. [PubMed: 23028171].
Habib AM, Dhanji AR, Mansour SA, Wood A, Awad WI. The EuroSCORE: a neglected measure of medium-term survival following
cardiac surgery. Interact Cardiovasc Thorac Surg. 2015;21(4):427–34. doi:
1093/icvts/ivv156. [PubMed: 26117842
- Abstract Viewed: 177 times
- PDF Downloaded: 0 times